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Short title: Body mass index, weight gain and pregnancy complications 
 
ABSTRACT 
Objective: To assess the separate and combined associations of maternal pre-pregnancy BMI 
and gestational weight gain with the risks of pregnancy complications and their population 
impact. 
Design: Individual participant data meta-analysis of 39 cohorts. 
Setting: Europe, North America and Oceania. 
Population: 265,270 births. 
Methods: Information on maternal pre-pregnancy BMI, gestational weight gain, and 
pregnancy complications was obtained. Multilevel binary logistic regression models were 
used. 
Main outcome measures: Gestational hypertension, pre-eclampsia, gestational diabetes, 
preterm birth, small and large size for gestational age at birth. 
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Results: Higher maternal pre-pregnancy BMI and gestational weight gain were, across their 
full ranges, associated with higher risks of gestational hypertensive disorders, gestational 
diabetes and large size for gestational age at birth. Preterm birth risk was higher at lower and 
higher BMI and weight gain. Compared to normal weight mothers with medium gestational 
weight gain, obese mothers with high gestational weight gain had the highest risk of any 
pregnancy complication (Odds Ratio 2.51 (95% Confidence Interval 2.31, 2.74)). We 
estimated that 23.9% of any pregnancy complication was attributable to maternal 
overweight/obesity and 31.6% of large size for gestational age infants was attributable to 
excessive gestational weight gain. 
 
Conclusions: Maternal pre-pregnancy BMI and gestational weight gain are, across their full 
ranges, associated with the risks of pregnancy complications. Obese mothers with high 
gestational weight gain are at the highest risk of pregnancy complications. Promoting a 
healthy pre-pregnancy BMI and gestational weight gain may reduce the burden of pregnancy 
complications and ultimately the risk of maternal and neonatal morbidity. 
 
Keywords: weight gain, body mass index, pregnancy complications, preterm birth, birth 
weight 
 
Tweetable abstract: Promoting a healthy body mass index and gestational weight gain might 
reduce the population burden of pregnancy complications. 
 
INTRODUCTION 
Obesity among women of reproductive age is increasing in prevalence worldwide.
1
 A meta-
analysis of published data of 38 cohorts reported that not only maternal obesity but also 
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modest increases in maternal body mass index (BMI) were associated with an increased risk 
of fetal and infant death. For women with a BMI of 30 kg/m
2
, absolute risks per 10,000
pregnancies were 102 and 43 fetal and infant deaths, respectively.
2
 Maternal overweight and
obesity are also associated with increased risks of more common pregnancy complications, 
such as gestational hypertensive disorders, gestational diabetes, preterm birth and large size 
for gestational age at birth.
3-5
 Next to maternal pre-pregnancy BMI, excessive gestational
weight gain, defined by the US Institute of Medicine (IOM) criteria, is associated with 
increased risks of pregnancy complications.
6-9
 However, most previous studies have lacked
power to robustly assess whether differences in risk are also present for modest changes in 
maternal pre-pregnancy BMI and gestational weight gain and by severity of obesity. 
Although the associations of maternal obesity and excessive weight gain with pregnancy 
complications have been extensively studied, less is known on the population disease burden 
attributable to these conditions.
10-12
 Gaining insight into the population attributable risks will
allow the development of future population preventive strategies designed to reduce the risks 
of common pregnancy complications. Furthermore, a meta-analysis of individual participant 
data (IPD) on this topic, in contrast to the previously performed meta-analyses of published 
results,
4, 9
 allows more powerful and flexible analyses, better harmonization of the data,
consistent adjustment for potential confounders and leads to a reduced risk of publication 
bias. 
Therefore, we conducted a meta-analysis of IPD among 265,270 singleton births from 39 
American, European and Oceania pregnancy and birth cohorts to assess the associations of 
maternal pre-pregnancy BMI and gestational weight gain with the risks of gestational 
hypertension, pre-eclampsia, gestational diabetes, preterm birth, and small and large size for 
gestational age at birth and to assess their population impact. 
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METHODS 
Inclusion criteria and participating cohorts 
We used data from an existing international collaboration on maternal obesity and childhood 
outcomes. Pregnancy and birth cohort studies were eligible if they included mothers with 
singleton live-born children born from 1989 onwards, had information available on maternal 
pre- or early-pregnancy BMI and at least one offspring measurement (birth weight or 
childhood BMI) and were approved by their local institutional review boards. We invited 50 
cohorts from Europe, North America and Oceania selected from existing collaborations on 
childhood health (EarlyNutrition Project, CHICOS Project, www.birthcohorts.net assessed 
until July 2014), of which 39 agreed to participate, providing data of 277,042 singleton births. 
Of those, information on maternal pre- or early-pregnancy BMI and at least one pregnancy 
complication was available for 265,270 singleton births (flowchart in Figure S1). 
Anonymized datasets were stored on a single central secured data server with access for the 
main analysts (SS, EV). A description of the eligibility criteria and the references of the study 
design and profile papers of each included cohort are given in Table S1. Participants were 
not involved in the development of the study. 
 
Maternal anthropometrics 
Maternal anthropometrics were measured, derived from clinical records or self-reported 
(cohort-specific information in Table S2). Maternal BMI before pregnancy, available in 96% 
of the study population, was used in the analyses. For participants without information on 
pre-pregnancy BMI, BMI obtained before 20 weeks of gestation was used. Maternal BMI 
was categorized into underweight (<18.5 kg/m
2
), normal weight (18.5–24.9 kg/m
2
),
overweight (25.0–29.9 kg/m
2
), obesity grade 1 (30.0–34.9 kg/m
2
), obesity grade 2 (35.0–39.9
kg/m
2
), and obesity grade 3 (≥40.0 kg/m
2
),
13
 and into 11 groups with a range of 2.5 kg/m
2
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each. Information on total gestational weight gain, defined as the difference between the 
latest weight before delivery and pre-pregnancy weight, was provided by the cohorts and was 
classified as inadequate, adequate, or excessive weight gain in relation to maternal pre-
pregnancy BMI according to the IOM guidelines.
14
 We calculated weight gain until 20 weeks
of gestation as the difference between a weight obtained until median 15.4 weeks (95% range 
10.0, 19.3) and pre-pregnancy weight. We calculated maternal pre-pregnancy BMI specific 
weight gain for gestational age z-scores based on reference charts created using data from this 
collaboration (Appendix S1).
15
 These z-scores were categorized into 6 categories (<-2.0
standard deviation (SD), -2.0 to -1.1 SD, -1.0 to -0.1 SD, 0 to 0.9 SD, 1.0 to 1.9 SD and ≥2.0 
SD) and into low (≤-1.1 SD), medium (-1.0 to 0.9 SD) and high (≥1.0 SD) weight gain. 
 
Pregnancy complications 
Information on gestational hypertension, pre-eclampsia, gestational diabetes, gestational age 
at birth and birth weight was measured, derived from clinical records or reported (cohort-
specific information in Table S2). Preterm birth was defined as <37 weeks of gestation.
16
 We
created sex- and gestational age-adjusted birth weight SD scores based on a North-European 
reference chart.
17
 Small and large size for gestational age at birth were defined per cohort as
sex- and gestational age-adjusted birth weight below the 10
th
 percentile and above the 90
th
percentile, respectively. Any pregnancy complication was defined as at least one of the 
pregnancy complications. A core outcome set was not used in this study. 
 
Covariates 
Information on covariates was assessed by questionnaires and provided by the cohorts as 
categorical covariates: educational level (low, medium, high), parity (nulliparous, 
multiparous), smoking habits during pregnancy (yes, no), and child’s sex. Maternal age was 
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categorized based on data availability as <25.0, 25.0-29.9, 30.0-34.9, and ≥35.0 years. As 
part of the analysis plan, covariates were selected based on the graphical criteria for 
confounding and data availability in the cohorts.
18
 Maternal ethnicity was not included due to
the fact that most cohorts were largely Caucasian and a high percentage of missings in ethnic 
specific information. Cohort-specific information is given in Table S3. 
 
Statistical analysis 
We conducted one-stage IPD meta-analysis by analyzing individual level data from all 
cohorts simultaneously in a multilevel model. Our model followed a two-level hierarchical 
structure with participants (level 1) nested within cohorts (level 2).
19
 We used generalized
linear mixed models with a binomial distribution and logit link. We defined the models 
assuming a random intercept at cohort level to allow variation in the baseline risk for each 
cohort. We used these models to examine the separate and combined associations of maternal 
pre-pregnancy BMI and gestational weight gain, in clinical categories and across the full 
range, with the risks of pregnancy complications. We only examined the associations of 
gestational weight gain clinical categories with the risks of small and large size for 
gestational age at birth due to the possibility of reverse causality for the other outcomes. The 
associations of excessive weight gain with gestational hypertensive disorders might be partly 
explained by pathologic fluid retention as part of the disease. Women diagnosed with 
gestational diabetes might try to improve their diet and restrict their total weight gain. 
Preterm birth shortens the gestation and thus women are less likely to gain excessive 
gestational weight. The proportion of pregnancy complications at a population-level 
attributable to each maternal pre-pregnancy BMI and gestational weight gain clinical 
category was estimated by calculation of population attributable risk fractions. For this, we 
used the adjusted Odds Ratio (OR) and the prevalence of the exposure category in the 
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population.
20
 To study the effects of weight gain across the full range on gestational
hypertension, pre-eclampsia and gestational diabetes, we used weight gain z-scores until 20 
weeks of gestation to avoid reverse causality. For the models using maternal pre-pregnancy 
BMI and gestational weight gain z-scores continuously, the inclusion of quadratic terms did 
not improve the fit. We did not observe statistical interactions between both maternal BMI 
and gestational weight gain with child’s sex. All models were adjusted for maternal age, 
educational level, parity, and smoking habits during pregnancy. Models for birth 
complications were additionally adjusted for child’s sex. Models for weight gain across the 
full range were also adjusted for maternal pre-pregnancy BMI. As sensitivity analyses, we 
conducted two-stage IPD meta-analyses and tested for heterogeneity between the cohorts 
estimates.
19, 21
 We used missing values in covariates as an additional group to prevent
exclusion of non-complete cases. We performed statistical analyses using the Statistical 
Package of Social Sciences version 21.0 for Windows (SPSS Inc, Chicago, IL, USA) and 
Review Manager (RevMan) version 5.3 of the Cochrane Collaboration (The Nordic Cochrane 
Centre, Copenhagen, Denmark). 
 
RESULTS 
 
Participants’ characteristics 
Table S4 shows cohort-specific information on maternal anthropometrics and pregnancy 
complications. Overall, the median maternal pre/early-pregnancy BMI and total gestational 
weight gain were 22.7 kg/m
2
 (95% range: 18.1-34.7 kg/m
2
), and 14.0 kg (95% range: 3.9-
27.0 kg), respectively. 
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Maternal pre-pregnancy BMI and risks of pregnancy complications 
Table 1 shows that, as compared to normal weight mothers, underweight, overweight and 
obesity grades 1 to 3 mothers had higher risks of any pregnancy complication (all p-
values<0.05). The highest risk of any pregnancy complication was observed for obesity grade 
3 mothers (OR 2.99 (95% Confidence Interval (CI) 2.68, 3.34)). Mothers with obesity grade 
3 had also the highest risks of gestational hypertension (OR 5.40 (95% CI 4.47, 6.51)), pre-
eclampsia (OR 6.50 (95% CI 5.48, 7.73)), gestational diabetes (OR 7.59 (95% CI 6.14, 
9.38)), preterm birth (OR 1.52 (95% CI 1.24, 1.87)) and large size for gestational age at birth 
(OR 3.06 (95% CI 2.69, 3.49)). We estimated that 23.9% of any pregnancy complication, and 
specifically, 35.6% of gestational hypertension, 34.6% of pre-eclampsia, 42.8% of gestational 
diabetes, 3.9% of preterm birth and 20.6% of large size for gestational age at birth were 
attributable to maternal overweight and obesity (Table 1). 
Figure 1 shows that higher maternal pre-pregnancy BMI was across the full range associated 
with higher risks of gestational hypertensive disorders, gestational diabetes and large size for 
gestational age at birth and with a lower risk of small size for gestational age at birth (p-
values<0.05). Both lower and higher maternal pre-pregnancy BMI were associated with a 
higher risk of preterm birth (p-values<0.05). Similar results were observed in the unadjusted 
models (Table S5 and Figure S2). The risks of pregnancy complications per kg/m
2
 are given
in the footnotes of Figure 1 and Figure S2. Similar results were observed in two-stage IPD 
meta-analysis (Figure S3). 
 
Gestational weight gain and risks of pregnancy complications 
Table 1 shows that, as compared to mothers with adequate gestational weight gain, mothers 
with excessive gestational weight gain had a lower risk of small size for gestational age at 
birth (OR 0.62 (95% CI 0.60, 0.65)) and a higher risk of large size for gestational age at birth 
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(OR 2.11 (95% CI 2.04, 2.18)). We estimated that 11.0% of small size for gestational age at 
birth and 31.6% of large size for gestational age at birth were attributable to inadequate and 
excessive gestational weight gain, respectively. 
 
Figure 2 shows that higher weight gain z-scores until 20 weeks of gestation were associated 
with higher risks of gestational hypertension, pre-eclampsia and gestational diabetes. Both 
lower and higher total gestational weight gain z-scores were associated with a higher risk of 
preterm birth (p-values<0.05). Higher total gestational weight gain z-scores were, across the 
full range, associated with a lower risk of small size for gestational age at birth and a higher 
risk of large size for gestational age at birth (p-values<0.05). Similar results were observed in 
the unadjusted models (Table S5 and Figure S4). The risks of pregnancy complications per 
SD increase in gestational weight gain are given in the footnotes of Figure 2 and Figure S4. 
Similar results were observed in two-stage IPD meta-analysis (Figure S5). 
 
Maternal pre-pregnancy BMI and gestational weight gain and risks of pregnancy 
complications 
Table 2 shows that, as compared to normal weight mothers with medium gestational weight 
gain, overweight and obese mothers had higher risks of any pregnancy complication, 
independent of their gestational weight gain (p-values<0.05). The highest risk of any 
pregnancy complication was observed for obese mothers with high weight gain (OR 2.51 
(95% CI 2.31, 2.74)). Low and high gestational weight gain were also, among normal weight 
mothers, associated with a higher risk of any pregnancy complication (p-values<0.05). Obese 
mothers with high gestational weight gain had the highest risks of gestational hypertension 
(OR 4.52 (95% CI 3.86, 5.31)), pre-eclampsia (OR 4.58 (95% CI 3.90, 5.37)), gestational 
diabetes (OR 7.84 (95% CI 6.38, 9.62)), preterm birth (OR 2.14 (95% CI 1.86, 2.46)) and 
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large size for gestational age at birth (OR 4.77 (95% CI 4.35, 5.22)). Underweight mothers 
with low gestational weight gain had the highest risk of small size for gestational age at birth 
(OR 3.12 (95% CI 2.75, 3.54)). Similar results were observed in the unadjusted models 
(Table S6). 
 
DISCUSSION 
Main findings 
In this IPD meta-analysis, higher maternal pre-pregnancy BMI and gestational weight gain 
were, across the full range, associated with higher risks of gestational hypertensive disorders, 
gestational diabetes and large size for gestational age at birth. Preterm birth risk was higher at 
both BMI and weight gain extremes. Obese mothers with high gestational weight gain had 
the highest risk of any pregnancy complication. We estimated that up to 24% of any 
pregnancy complication could be attributed to maternal overweight and obesity, whereas up 
to 32% of large size for gestational age infants could be attributed to excessive gestational 
weight gain. However, the estimated population attributable risks should be carefully 
interpreted since the causality of the observed associations remains unknown. 
 
Strengths and limitations 
We performed a large meta-analysis of IPD from many cohorts. As part of an international 
collaboration between pregnancy and birth cohort studies, we invited all cohorts from 
Europe, North America, and Oceania that we were able to identify from existing large 
international collaborations on childhood health and that met the inclusion criteria. Therefore, 
we believe this meta-analysis covers a large proportion of individual participant data 
available on this topic. However, we cannot disregard the possibility of data missing from 
other cohorts, especially recent cohorts, that were not included. We did not rely on published 
A
cc
ep
te
d
 A
rt
ic
le
 
data, limiting any potential publication bias and enabling a consistent definition of exposures, 
confounders and outcomes. The large sample size enabled us to study the risks of pregnancy 
complications in relatively rare conditions, such as severe obesity. We did not consider 
additional levels, such as country and continent, in our multilevel modelling due to the high 
computational complexity required for this approach and the likely minimal influence of this 
on the findings. We performed two-stage meta-analyses as sensitivity analyses, which gave 
similar results and showed moderate-to-high heterogeneity between the cohorts estimates. 
Missing values of covariates were used as an additional group. This approach, although 
commonly used in large IPD meta-analyses due to the constraints in applying more advanced 
imputation strategies, might lead to bias.
22
 However, in the current study, bias is unlikely
considering the small percentage of missings and the similar findings between unadjusted and 
adjusted models. We relied on weights obtained partly by self-report, which might be a 
source of error. However, a large systematic review showed that reporting error did not bias 
associations between pregnancy-related weight and birth outcomes.
23
 We used maternal pre-
pregnancy BMI specific weight gain for gestational age z-scores, which classify weight gain 
independently of gestational age.
15
 This approach allows assessing the unbiased associations
between gestational weight gain and pregnancy outcomes that are highly correlated with 
gestational age at birth. This method is needed because the absolute value related to the z-
score changes across pregnancy. However, the use of z-scores might complicate the clinical 
interpretation of the observed associations. Some cohorts relied on self-reporting to obtain 
information on gestational hypertensive and diabetic disorders. If misclassification of women 
occurred, our associations might be attenuated. As in any observational study, residual 
confounding by unmeasured lifestyle related variables may be an issue. 
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Interpretation 
Maternal obesity is a major public health concern.
24
 A meta-analysis of published cohort
studies showed that maternal obesity is associated with a higher risk of fetal and infant 
death.
2
 Maternal obesity is also associated with increased risks of more common pregnancy
complications, such as gestational hypertensive disorders, gestational diabetes, preterm birth 
and large size for gestational age at birth,
3-5
 which are important risk factors for both maternal
and neonatal morbidity and mortality.
25-28
 In line with these previous studies, we observed
that maternal pre-pregnancy overweight and obesity are related to increased risks of any of 
these pregnancy complications. Mothers with obesity grade 3 showed the highest risks. 
Importantly, we estimated that over 40% of gestational hypertensive and diabetic disorders 
could be attributed to maternal overweight and obesity. Smaller but yet considerable risk 
fractions attributable to maternal overweight/obesity were observed for preterm birth (3.9%) 
and large size for gestational age at birth (20.6%). Overall, 23.9% of any pregnancy 
complication was estimated to be attributable to maternal pre-pregnancy overweight/obesity, 
which underlines their major public health implications and the possibility to substantially 
reduce pregnancy complications by optimizing maternal BMI. 
The associations of maternal BMI with pregnancy complications were also present across the 
full range. Even modest increases of maternal pre-pregnancy BMI were associated with 
higher risks of gestational hypertensive disorders, gestational diabetes and large size for 
gestational age at birth. The association of maternal pre-pregnancy BMI with the risk of 
preterm birth tended to be U-shaped. Thus, our findings suggest that mothers do not 
necessarily need to become overweight or obese to be at risk of pregnancy complications, 
since higher risks of pregnancy complications were already observed for an increase in BMI 
within the healthy range. 
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Next to pre-pregnancy BMI, excessive gestational weight gain may affect the risks of 
pregnancy complications.
6-9
 We observed gradually higher risks of gestational hypertension,
pre-eclampsia and gestational diabetes over the full range of weight gain. Similar to the 
association of maternal BMI, the association of total gestational weight gain z-scores with 
preterm birth tended to be U-shaped. We also observed that not only excessive weight gain 
but also higher weight gain across the full range was associated with a higher risk of large 
size for gestational age at birth. At the population level, 31.6% of large size for gestational 
age infants could be attributed to excessive weight gain. Altogether, these findings suggest 
that gradual increases in gestational weight gain, and not only excessive weight gain, are 
associated with higher risks of pregnancy complications. 
 
We also assessed the combined effects of pre-pregnancy BMI and gestational weight gain on 
pregnancy complications. Previous studies showed that mothers with both high BMI and 
gestational weight gain had the highest risk of large size for gestational age. The risk of 
preterm birth was increased at both extremes.
29-33
 In line with these previous studies, we
observed that obese mothers with high weight gain were at the highest risk of any pregnancy 
complication. Importantly, we also observed that overweight and obese mothers are at risk of 
these complications, regardless how much weight they gain during pregnancy. These findings 
show the importance of promoting a healthy weight status before and during pregnancy. 
 
The mechanisms underlying the associations of maternal adiposity and pregnancy 
complications are not fully understood yet, but might include insulin resistance, endothelial 
dysfunction, oxidative stress, lipotoxicity, inflammation, and infection.
3, 4, 34
 The associations
of maternal adiposity with large size for gestational age infants might be explained by fetal 
over-nutrition, since an increased placental transfer of nutrients to the fetus might lead to an 
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increased synthesis of insulin and insulin-like growth factors, both of which are growth-
promoting hormones.
35
 The causal role of glucose is also suggested in a large Mendelian
randomization study.
36
 Gestational weight gain reflects fat storage during pregnancy, but also
reflects fetus growth, amniotic fluid, placenta, uterine and mammary tissue expansion, 
increased blood volume, and extracellular fluid.
37
 These factors may all have different roles
in the associations with pregnancy complications. From the current observational data, we 
cannot drive conclusions on the mechanisms underlying the observed associations. 
 
We observed that a high percentage of pregnancy complications is attributable to suboptimal 
maternal BMI and gestational weight gain, which suggests the potential for prevention of 
pregnancy complications by optimizing these maternal measures. Thus far, randomized trials 
focused on lifestyle interventions to improve gestational weight gain and subsequent 
pregnancy complications are disappointing. An IPD meta-analysis from randomized trials 
focused on lifestyle interventions in pregnancy showed a reduction in gestational weight gain 
but no effects on gestational hypertensive and diabetic disorders, preterm birth and size for 
gestational age.
38
 Strategies to improve body mass index before pregnancy rather than during
pregnancy may be more effective in prevention of pregnancy complications. 
 
CONCLUSION 
Maternal pre-pregnancy BMI and gestational weight gain are, across the full range, 
associated with the risks of pregnancy complications. Obese mothers with high gestational 
weight gain are at the highest risk of pregnancy complications. Up to 30% of any pregnancy 
complication is estimated to be attributable to overweight/obesity or excessive gestational 
weight gain. Our findings provide evidence for advocating a healthy BMI in women who are 
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planning to become pregnant and an adequate weight gain during pregnancy to reduce the 
burden of obstetric and neonatal morbidity. 
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TABLES TITLES/LEGENDS 
 
Table 1. Maternal pre-pregnancy body mass index and gestational weight gain clinical categories and 
the risks of pregnancy complications
a
 
 
a
ncases/total represent the number of cases for each pregnancy complication in each clinical category/the 
population in each clinical category. Values are odds ratios (95% confidence intervals) from 
multilevel binary logistic regression models that reflect the risk of pregnancy complications per pre-
pregnancy body mass index and gestational weight gain clinical category compared with the reference 
group (normal weight and adequate weight gain). Mothers diagnosed with pre-eclampsia were 
excluded from the models for gestational hypertension. The reference group for the analyses on pre-
eclampsia comprises the mothers without both pre-eclampsia and gestational hypertension. The 
reference group for the analyses on small and large size for gestational age at birth is appropriate size 
for gestational age at birth. Models are adjusted for maternal age, educational level, parity, and 
smoking habits during pregnancy. Models for birth complications are additionally adjusted for child's 
sex. *P-value<0.05; **P-value<0.001. PAR is the population attributable risk fraction in percentage 
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that reflect the proportion of pregnancy complications at a population-level attributable to each 
maternal pre-pregnancy body mass index and gestational weight gain clinical category. NA, not 
applicable. 
b
PAR calculated based on preterm birth and small size for gestational age at birth. 
c
PAR 
calculated based on gestational hypertension, pre-eclampsia, gestational diabetes, preterm birth and 
large size for gestational age at birth. 
 
 
 
Table 2. Maternal pre-pregnancy body mass index and gestational weight gain categories and the 
risks of pregnancy complications
a 
 
 
a
ncases/total represent the number of cases for each pregnancy complication in each group/the population 
in each group. Values are odds ratios (95% confidence intervals) from multilevel binary logistic 
regression models that reflect the risk of pregnancy complications per combined pre-pregnancy body 
mass index and gestational weight gain categories compared with the reference group (normal weight 
and medium weight gain). For any pregnancy complication, gestational hypertension, pre-eclampsia 
and gestational diabetes, weight gain z-scores until 20 weeks of gestation were used and for preterm 
birth, and small and large size for gestational age at birth, total gestational weight gain z-scores were 
used. Mothers diagnosed with pre-eclampsia were excluded from the models for gestational 
hypertension. The reference group for the analyses on pre-eclampsia comprises the mothers without 
both pre-eclampsia and gestational hypertension. The reference group for the analyses on small and 
large size for gestational age at birth is appropriate size for gestational age at birth. Models are 
adjusted for maternal age, educational level, parity, and smoking habits during pregnancy. Models for 
birth complications are additionally adjusted for child's sex. *P-value<0.05; **P-value<0.001. 
Significant interaction terms were present (p-values<0.05) for preterm birth, and small and large size 
for gestational age at birth. 
 
 
FIGURES TITLES/LEGENDS 
 
Figure 1. Maternal pre-pregnancy body mass index and the risks of pregnancy complications
a 
a
Values are odds ratios (95% confidence intervals) on a log scale from multilevel binary logistic 
regression models that reflect the risk of pregnancy complications per pre-pregnancy body mass index 
group compared with the reference group (largest group, 20.0-22.4 kg/m
2
). The bars represent the 
percentage of each pregnancy complication per body mass index group. Mothers diagnosed with pre-
eclampsia were excluded from the models for gestational hypertension. The reference group for the 
analyses on pre-eclampsia comprises the mothers without both pre-eclampsia and gestational 
hypertension. The reference group for the analyses on small and large size for gestational age at birth 
is appropriate size for gestational age at birth. Models are adjusted for maternal age, educational level, 
parity, and smoking habits during pregnancy. Models for birth complications are additionally adjusted 
for child's sex. Excel’s trendline function was used to fit the curve to the data. The risks of pregnancy 
complications per kg/m
2
 were: gestational hypertension OR 1.11 (95% CI: 1.11, 1.12), pre-eclampsia 
OR 1.11 (95% CI: 1.11, 1.12), gestational diabetes OR 1.12 (95% CI: 1.12, 1.13), preterm birth OR 
1.02 (95% CI: 1.01, 1.02), small size for gestational age at birth OR 0.96 (95% CI: 0.95, 0.96), and 
large size for gestational age at birth: OR 1.08 (95% CI 1.08, 1.08). 
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Figure 2. Gestational weight gain and the risks of pregnancy complications
a 
a
Values are odds ratios (95% confidence intervals) on a log scale from multilevel binary logistic 
regression models that reflect the risk of pregnancy complications per gestational weight gain group 
compared with the reference group (largest group, -1.0 to -0.1 SD). The bars represent the percentage 
of each pregnancy complication per gestational weight gain group. Mothers diagnosed with pre-
eclampsia were excluded from the models for gestational hypertension. The reference group for the 
analyses on pre-eclampsia comprises the mothers without both pre-eclampsia and gestational 
hypertension. The reference group for the analyses on small and large size for gestational age at birth 
is appropriate size for gestational age at birth. Models are adjusted for maternal age, educational level, 
parity, smoking habits during pregnancy and maternal pre-pregnancy body mass index. Models for 
birth complications are additionally adjusted for child's sex. Excel’s trendline function was used to fit 
the curve to the data. The risks of pregnancy complications per SD increase in gestational weight gain 
were: gestational hypertension OR 1.12 (95% CI: 1.09, 1.14), pre-eclampsia OR 1.07 (95% CI: 1.05, 
1.10), gestational diabetes OR 1.14 (95% CI: 1.10, 1.18), preterm birth OR 1.09 (95% CI: 1.07, 1.11), 
small size for gestational age at birth OR 0.73 (95% CI: 0.72, 0.74), and large size for gestational age 
at birth OR 1.53 (95% CI 1.51, 1.55). 
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Table 1. 
 
Pregnancy complications 
Odds Ratio (95% Confidence Interval) and Population Attributable Risk Fractions (PAR), % 
Any pregnancy 
complication 
Gestational 
hypertension 
Pre-eclampsia Gestational diabetes Preterm birth 
Small size for 
gestational age 
Large size for 
gestational age  
Pre-pregnancy body mass index 
 
  Underweight 
  (<18.5 kg/m2)
1.08 (1.03, 1.13)* 0.63 (0.55, 0.73)** 0.67 (0.57, 0.78)** 0.66 (0.53, 0.82)** 1.20 (1.10, 1.31)** 1.67 (1.58, 1.76)** 0.45 (0.41, 0.50)** 
PAR 2.3b NA NA NA PAR 0.8 PAR 2.7 NA 
ncases/total=3079/9586 ncases/total=216/9416 ncases/total=168/9368 ncases/total=85/10449 ncases/total=599/10455 ncases/total=1900/10382 ncases/total=383/8865 
 
  Normal weight 
  (18.5-24.9 kg/m2)
Reference Reference Reference Reference Reference Reference Reference 
ncases/total=46774/159983 ncases/total=5066/155612 ncases/total=4100/154646 ncases/total=1857/168117 ncases/total=7852/172123 ncases/total=18185/159778 ncases/total=14674/156267 
 
  Overweight 
  (25.0-29.9 kg/m2)
1.35 (1.32, 1.38)** 2.04 (1.94, 2.15)** 1.96 (1.86, 2.07)** 2.22 (2.06, 2.40)** 1.06 (1.01, 1.11)* 0.79 (0.76, 0.82)** 1.61 (1.56, 1.66)** 
PAR 11.4c PAR 17.1 PAR 16.0 PAR 19.4 PAR 1.2 NA PAR 10.8 
ncases/total=16817/47825 ncases/total=2531/45509 ncases/total=2202/45180 ncases/total=1156/49203 ncases/total=2433/50852 ncases/total=4074/44476 ncases/total=6837/47239 
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  Obesity  
  (≥30.0 kg/m2)
2.02 (1.96, 2.08)** 3.68 (3.46, 3.91)** 3.70 (3.48, 3.93)** 4.59 (4.22, 4.99)** 1.33 (1.25, 1.41)** 0.79 (0.75, 0.83)** 2.28 (2.19, 2.37)** 
PAR 12.5c PAR 18.5 PAR 18.6 PAR 23.4 PAR 2.7 NA PAR 9.8 
ncases/total=9330/20834 ncases/total=1687/18863 ncases/total=1621/18797 ncases/total=1020/21148 ncases/total=1322/21992 ncases/total=1694/18134 ncases/total=3929/20369 
 
    Obesity grade 1 
    (30.0-34.9 kg/m2)
1.87 (1.80, 1.93)** 3.31 (3.08, 3.55)** 3.20 (2.98, 3.44)** 3.97 (3.61, 4.37)** 1.30 (1.21, 1.39)** 0.78 (0.73, 0.83)** 2.15 (2.05, 2.25)** 
PAR 8.2c PAR 12.5 PAR 12.0 PAR 15.5 PAR 1.8 NA PAR 6.6 
ncases/total=6505/15181 ncases/total=1136/13900 ncases/total=1047/13811 ncases/total=636/15405 ncases/total=936/16006 ncases/total=1235/13363 ncases/total=2725/14853 
 
  Obesity grade 2 
   (35.0-39.9 kg/m2)
2.36 (2.21, 2.51)** 4.66 (4.17, 5.20)** 4.81 (4.31, 5.37)** 5.85 (5.09, 6.73)** 1.38 (1.22, 1.57)** 0.79 (0.71, 0.89)** 2.56 (2.37, 2.77)** 
PAR 3.7c PAR 6.1 PAR 6.3 PAR 7.9 PAR 0.7 NA PAR 2.7 
ncases/total=2091/4308 ncases/total=412/3812 ncases/total=410/3810 ncases/total=271/4386 ncases/total=287/4557 ncases/total=345/3662 ncases/total=888/4205 
 
  Obesity grade 3 
     (≥40.0 kg/m2)
2.99 (2.68, 3.34)** 5.40 (4.47, 6.51)** 6.50 (5.48, 7.73)** 7.59 (6.14, 9.38)** 1.52 (1.24, 1.87)** 0.86 (0.70, 1.04) 3.06 (2.69, 3.49)** 
PAR 1.7c PAR 2.4 PAR 2.9 PAR 3.5 PAR 0.3 NA PAR 1.1 
ncases/total=734/1345 ncases/total=139/1151 ncases/total=164/1176 ncases/total=113/1357 ncases/total=99/1429 ncases/total=114/1109 ncases/total=316/1311 
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Gestational weight gain 
  Inadequate weight gain 
1.57 (1.51, 1.63)** 0.65 (0.62, 0.68)** 
PAR 11.0 NA 
ncases/total=6512/40322 ncases/total=2150/35960 
  Adequate weight gain 
Reference Reference 
ncases/total=7406/66330 ncases/total=5592/64516 
  Excessive weight gain 
0.62 (0.60, 0.65)** 2.11 (2.04, 2.18)** 
NA PAR 31.6 
ncases/total=5632/70709 ncases/total=11994/77071 
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Table 2. 
Pregnancy complications 
Odds Ratio (95% Confidence Interval) 
Any pregnancy 
complication 
Gestational 
hypertension 
Pre-eclampsia Gestational diabetes Preterm birth 
Small size for 
gestational age 
Large size for 
gestational age 
Underweight 
Low weight gain  
(≤-1.1 SD) 
1.09 (0.94, 1.26) 0.56 (0.39, 0.79)* 0.45 (0.26, 0.78)* 1.39 (0.77, 2.49) 1.82 (1.47, 2.27)** 3.12 (2.75, 3.54)** 0.23 (0.15, 0.35)** 
ncases/total=310/960 ncases/total=33/1002 ncases/total=13/982 ncases/total=12/1077 ncases/total=92/1304 ncases/total=360/1332 ncases/total=21/993 
Medium weight gain 
(-1.0 to 0.9 SD) 
1.04 (0.96, 1.12) 0.65 (0.51, 0.81)** 0.68 (0.53, 0.86)* 0.55 (0.34, 0.90)* 1.24 (1.08, 1.42)* 1.76 (1.63, 1.90)** 0.45 (0.38, 0.53)** 
ncases/total=1139/4022 ncases/total=81/3999 ncases/total=68/3986 ncases/total=17/4302 ncases/total=231/4890 ncases/total=889/4916 ncases/total=164/4191 
High weight gain  
(≥1.0 SD) 
1.13 (0.98, 1.30) 1.07 (0.76, 1.50) 1.22 (0.82, 1.79) 0.56 (0.23, 1.36) 1.23 (0.97, 1.57) 0.79 (0.67, 0.95)* 0.98 (0.79, 1.22) 
ncases/total=330/1021 ncases/total=37/974 ncases/total=27/964 ncases/total=5/1152 ncases/total=72/1396 ncases/total=145/1324 ncases/total=88/1267 
Normal weight 
Low weight gain  
(≤-1.1 SD) 
1.04 (1.01, 1.08)* 0.98 (0.90, 1.07) 1.02 (0.92, 1.13) 0.90 (0.73, 1.09) 1.17 (1.09, 1.26)** 1.81 (1.73, 1.89)** 0.52 (0.49, 0.56)** 
ncases/total=5702/19877 ncases/total=853/19649 ncases/total=539/19335 ncases/total=136/20792 ncases/total=946/21290 ncases/total=3647/20991 ncases/total=885/18229 
Medium weight gain 
(-1.0 to 0.9 SD) 
Reference Reference Reference Reference Reference Reference Reference 
ncases/total=17957/68457 ncases/total=1918/66938 ncases/total=1606/66626 ncases/total=497/70805 ncases/total=3196/84958 ncases/total=8584/79555 ncases/total=6592/77563 
High weight gain  
(≥1.0 SD) 
1.10 (1.06, 1.14)** 1.39 (1.28, 1.52)** 1.24 (1.12, 1.37)** 1.34 (1.14, 1.58)** 1.34 (1.25, 1.43)** 0.57 (0.54, 0.61)** 2.26 (2.17, 2.37)** 
ncases/total=5910/20051 ncases/total=817/19247 ncases/total=530/18960 ncases/total=218/20991 ncases/total=1321/25135 ncases/total=1607/21532 ncases/total=3674/23599 
Overweight 
Low weight gain  
(≤-1.1 SD) 
1.23 (1.16, 1.32)** 1.46 (1.25, 1.71)** 1.86 (1.61, 2.15)** 1.91 (1.46, 2.50)** 1.15 (1.01, 1.30)* 1.23 (1.14, 1.33)** 0.92 (0.84, 1.01) 
ncases/total=1541/5219 ncases/total=185/5024 ncases/total=217/5056 ncases/total=62/5333 ncases/total=278/6510 ncases/total=759/6117 ncases/total=496/5854 
Medium weight gain 
(-1.0 to 0.9 SD) 
1.38 (1.33, 1.43)** 2.10 (1.94, 2.27)** 2.10 (1.93, 2.28)** 2.40 (2.09, 2.75)** 1.07 (1.00, 1.15) 0.77 (0.73, 0.81)** 1.77 (1.69, 1.85)** 
ncases/total=7096/21817 ncases/total=1118/20804 ncases/total=986/20672 ncases/total=368/22326 ncases/total=1025/25596 ncases/total=1930/22445 ncases/total=3390/23905 
High weight gain 
(≥1.0 SD) 
1.63 (1.54, 1.73)** 2.71 (2.41, 3.06)** 2.54 (2.23, 2.90)** 3.49 (2.89, 4.22)** 1.49 (1.34, 1.66)** 0.51 (0.46, 0.57)** 3.46 (3.24, 3.69)** 
ncases/total=2089/5613 ncases/total=361/5237 ncases/total=282/5158 ncases/total=153/5767 ncases/total=395/6911 ncases/total=368/5460 ncases/total=1423/6515 
Obesity 
Low weight gain  1.70 (1.56, 1.85)** 3.06 (2.57, 3.66)** 3.52 (3.00, 4.14)** 4.44 (3.41, 5.77)** 1.36 (1.15, 1.62)** 0.99 (0.87, 1.12) 1.45 (1.29, 1.63)** 
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(≤-1.1 SD) ncases/total=916/2534 ncases/total=148/2344 ncases/total=182/2378 ncases/total=68/2577 ncases/total=148/2957 ncases/total=279/2639 ncases/total=337/2697 
Medium weight gain 
(-1.0 to 0.9 SD) 
2.06 (1.96, 2.16)** 3.88 (3.53, 4.26)** 4.01 (3.64, 4.40)** 5.09 (4.40, 5.89)** 1.32 (1.20, 1.46)** 0.80 (0.74, 0.86)** 2.57 (2.43, 2.72)** 
ncases/total=3818/9080 ncases/total=724/8208 ncases/total=695/8179 ncases/total=344/9220 ncases/total=534/10807 ncases/total=810/8924 ncases/total=1928/10042 
High weight gain 
(≥1.0 SD) 
2.51 (2.31, 2.74)** 4.52 (3.86, 5.31)** 4.58 (3.90, 5.37)** 7.84 (6.38, 9.62)** 2.14 (1.86, 2.46)** 0.60 (0.51, 0.70)** 4.77 (4.35, 5.22)** 
ncases/total=1098/2323 ncases/total=202/2074 ncases/total=194/2066 ncases/total=134/2374 ncases/total=230/2820 ncases/total=165/2085 ncases/total=732/2652 
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